Inmune Bio INMB Earnings Call Transcripts

NASDAQ INMB
$1.10 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST
10 earnings calls on file for Inmune Bio, from Q4 2020 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Inmune Bio Q3 2026 Earnings Call

Nov 5, 2026 3,751 words · 16 min read
  • Daniel Frederick Carlsonhead of investor relations
  • David J. MossCEO and Co-Founder
  • Dr. Mark LowdellChief Scientific Officer and cofounder
  • Cory EllspermannCFO
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Inmune Bio Earnings Call Transcripts

Calls10
LatestNov 5, 2026
SinceQ4 2020

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 10 Inmune Bio transcripts Register to get access to Inmune Bio’s earnings call transcripts.